elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38303998-11F813F4-4FB1-4164-81E8-78050CEE3AD3
Q38303998-11F813F4-4FB1-4164-81E8-78050CEE3AD3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38303998-11F813F4-4FB1-4164-81E8-78050CEE3AD3
Evolution from double to triple-antimalarial drug combinations.
P921
Q38303998-11F813F4-4FB1-4164-81E8-78050CEE3AD3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38303998-11F813F4-4FB1-4164-81E8-78050CEE3AD3
rank
NormalRank
type
BestRank
Statement
P921
antimalarial